This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Mcgill University, Elanco US Inc., Novartis Ag. Active years: 2014-2025.
Location History:
- Montreal, CA (2014)
- Quebec, CA (2018 - 2022)
Company Filing History:
4 out of 570 
2 out of 51 
1 out of 3,974 
Years Active: 2014-2025
Title: The Innovations of Catherine Bourguinat
Introduction
Catherine Bourguinat is a notable inventor based in California, recognized for her contributions to the field of veterinary medicine. She has been instrumental in developing innovative solutions to combat heartworm disease in animals. With a total of 4 patents, her work has significantly advanced the understanding of drug resistance in nematodes.
Latest Patents
One of her latest patents focuses on markers to predict macrocyclic lactone drug resistance in the causative agent of heartworm disease. This patent discloses nucleic acid molecules from the genome of specific nematodes that contain single nucleotide polymorphisms related to reduced responsiveness to macrocyclic lactones. The patent also outlines methods for determining the responsiveness of these nematodes to macrocyclic lactones, as well as methods for selecting appropriate treatments for animals infected with these nematodes. Additionally, it includes kits designed to assess the responsiveness of nematodes to macrocyclic lactones.
Career Highlights
Catherine has worked with prestigious institutions such as McGill University and Elanco US Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her research and innovation capabilities.
Collaborations
Throughout her career, Catherine has collaborated with notable colleagues, including Roger K. Prichard and Timothy G. Geary. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Catherine Bourguinat's innovative work in the field of veterinary medicine has made a significant impact on the understanding and treatment of heartworm disease. Her patents and collaborations reflect her dedication to improving animal health through scientific advancements.